Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4’,4’’,4’’’-(carbonylbis(imino-5,1,3-ben-zenetriylbis-(carbonylimino)))tetrakis -benzene-1,3-disulfonic acid octasodium salt] - Hechler, B; Magnenat, S; Zighetti, ML (J Pharmacol Exp Therapeut, 2005)